Merit Medical Q3 revenue up 7.8% to $339.8M, non-GAAP EPS $0.86, raises guidance

MERIT MEDICAL SYSTEMS INC

2024-Q3 EPS reported $1.57 revenue$1,001,356,000

Revenue $339.8M (+7.8% YoY); GAAP EPS $0.48 (+8.0%); non-GAAP EPS $0.86 (+21.1%).
Non-GAAP operating margin 19.2% vs 17.4% prior year; free cash flow $120M in 9 months (+116%).
Acquired assets from EndoGastric Solutions (EsophyX Z+ for GERD treatment).
Entered asset purchase for Cook Medical lead management portfolio; closing expected Nov 1, 2024.
Raised full-year guidance; specifics not detailed in press release excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.